XML 84 R57.htm IDEA: XBRL DOCUMENT v3.24.1
Equity-Based Compensation (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Equity-based compensation            
Number of shares granted to independent directors (in shares) 203,742 116,712 66,840      
Equity-based compensation expense       $ 226,250 $ 206,917 $ 230,083
Unrecognized equity-based compensation $ 240,000 $ 211,250   $ 240,000 $ 211,250  
Restricted stock            
Equity-based compensation            
Number of shares authorized (in shares) 2,000,000     2,000,000    
Restricted common shares grant vesting period       2 years    
Restricted Stock Units (RSUs)            
Equity-based compensation            
Restricted common shares grant vesting period       2 years    
Share-based compensation arrangement by share-based payment award shares issued per award exercised (in shares) 1     1    
Unvested shares (in shares) 77,741 54,114   77,741 54,114  
Independent Directors | Restricted stock            
Equity-based compensation            
Number of shares granted to independent directors (in shares)       159,932    
Aggregate value for restricted common shares granted to independent directors $ 1,300,000     $ 1,300,000    
Independent Directors | Restricted Stock Units (RSUs)            
Equity-based compensation            
Number of shares granted to independent directors (in shares)       203,742    
Aggregate value for restricted common shares granted to independent directors $ 700,000     $ 700,000